Lung fibrosis-associated surfactant protein A1 and C variants induce latent transforming growth factor β1 secretion in lung epithelial cells

J Biol Chem. 2013 Sep 20;288(38):27159-27171. doi: 10.1074/jbc.M113.475335. Epub 2013 Aug 7.

Abstract

Missense mutations of surfactant proteins are recognized as important causes of inherited lung fibrosis. Here, we study rare and common surfactant protein (SP)-A1 and SP-C variants, either discovered in our familial pulmonary fibrosis cohort or described by others. We show that expression of two SP-A1 (R219W and R242*) and three SP-C (I73T, M71V, and L188Q) variant proteins lead to the secretion of the profibrotic latent transforming growth factor (TGF)-β1 in lung epithelial cell lines. The secreted TGF-β1 is capable of autocrine and paracrine signaling and is dependent upon expression of the latent TGF-β1 binding proteins. The dependence upon unfolded protein response (UPR) mediators for TGF-β1 induction differs for each variant. TGF-β1 secretion induced by the expression of the common SP-A1 R219W variant is nearly completely blocked by silencing the UPR transducers IRE-1α and ATF6. In contrast, the secretion of TGF-β1 induced by two rare SP-C mutant proteins (I73T and M71V), is largely unaffected by UPR silencing or by the addition of the small molecular chaperone 4-phenylbutyric acid, implicating a UPR-independent mechanism for these variants. Blocking TGF-β1 secretion reverses cell death of RLE-6TN cells expressing these SP-A1 and SP-C variants suggesting that anti-TGF-β therapeutics may be beneficial to this molecularly defined subgroup of pulmonary fibrosis patients.

Keywords: Genetics; Pulmonary Fibrosis; Pulmonary Surfactant; Transforming Growth Factor Beta (TGFbeta); Unfolded Protein Response.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural
  • Retracted Publication

MeSH terms

  • Amino Acid Substitution
  • Animals
  • Antineoplastic Agents / pharmacology
  • Autocrine Communication / drug effects
  • Autocrine Communication / genetics
  • Cell Death / drug effects
  • Cell Death / genetics
  • Cell Line
  • Epithelial Cells / metabolism*
  • Epithelial Cells / pathology
  • Female
  • Humans
  • Male
  • Molecular Chaperones / pharmacology
  • Mutation, Missense*
  • Papio
  • Paracrine Communication / drug effects
  • Paracrine Communication / genetics
  • Phenylbutyrates / pharmacology
  • Pulmonary Fibrosis / genetics
  • Pulmonary Fibrosis / metabolism*
  • Pulmonary Fibrosis / pathology
  • Pulmonary Surfactant-Associated Protein A / genetics
  • Pulmonary Surfactant-Associated Protein A / metabolism*
  • Pulmonary Surfactant-Associated Protein C / genetics
  • Pulmonary Surfactant-Associated Protein C / metabolism*
  • Respiratory Mucosa / metabolism*
  • Respiratory Mucosa / pathology
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism*
  • Unfolded Protein Response / drug effects
  • Unfolded Protein Response / genetics

Substances

  • Antineoplastic Agents
  • Molecular Chaperones
  • Phenylbutyrates
  • Pulmonary Surfactant-Associated Protein A
  • Pulmonary Surfactant-Associated Protein C
  • SFTPA1 protein, human
  • SFTPC protein, human
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • 4-phenylbutyric acid